New comment by Radiation Oncologist at University of Maryland School of Medicine ( February 22, 2024)
Yes. We have achieved favorable disease control, cosmetic outcomes, and functional preservation for T1-3 tumors w/wo oral commissure involvement using HDR. We typically use 1-...